Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tasimelteon (BMS-214778) is a melatonin receptor agonist that is used for the treatment of non-24 hour sleep-wake disorder in blind individuals.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 11,500 | |||
10 mg | 在庫あり | ¥ 16,000 | |||
25 mg | 在庫あり | ¥ 30,500 | |||
50 mg | 在庫あり | ¥ 53,500 | |||
100 mg | 在庫あり | ¥ 79,500 | |||
500 mg | 在庫あり | ¥ 188,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 11,500 |
説明 | Tasimelteon (BMS-214778) is a melatonin receptor agonist that is used for the treatment of non-24 hour sleep-wake disorder in blind individuals. |
ターゲット&IC50 | MT2 receptor:9.8(pKi), MT1 receptor:9.45(pKi) |
別名 | VEC-162, BMS-214778 |
分子量 | 245.32 |
分子式 | C15H19NO2 |
CAS No. | 609799-22-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (203.82 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tasimelteon 609799-22-6 GPCR/G Protein Neuroscience MT Receptor Melatonin Receptor orally MT2 VEC162 DMRA MT1 Inhibitor VEC-162 regulator Non-24 inhibit BMS-214778 VEC 162 BMS 214778 circadian BMS214778 inhibitor